Japan ensures supply chain integrity in drug quality audits through stringent regulatory frameworks, including Good Manufacturing Practices (GMP) and the Pharmaceutical and Medical Devices Agency (PMDA) oversight. Regular inspections, risk assessments, and collaboration with international bodies help maintain high standards, ensuring drug safety, efficacy, and compliance with global quality benchmarks.
